Global Lung Cancer Genomic Testing Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Lung Cancer Genomic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Genomic Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Genomic Testing market in any manner.
Global Lung Cancer Genomic Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CD Genomics
Qiagen NV
Laboratory Corporation of America Holdings
NeoGenomics Laboratories
Agilent Technologies Inc.
Illumina Inc.
Thermo Fischer Scientific Inc.
Abbott Laboratories Inc.
Quest Diagnostics Inc.
OncoDNA
Centogene N.V.
Admera Health
CeGaT GmbH
OPKO Health Inc.
F. Hoffmann-La Roche AG.
Market Segmentation (by Type)
Liquid Biopsy
Tissue Biopsy
Market Segmentation (by Application)
Hospitals/Clinics
Research Organization
Diagnostic Laboratories
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Genomic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Lung Cancer Genomic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Genomic Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Genomic Testing market in any manner.
Global Lung Cancer Genomic Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CD Genomics
Qiagen NV
Laboratory Corporation of America Holdings
NeoGenomics Laboratories
Agilent Technologies Inc.
Illumina Inc.
Thermo Fischer Scientific Inc.
Abbott Laboratories Inc.
Quest Diagnostics Inc.
OncoDNA
Centogene N.V.
Admera Health
CeGaT GmbH
OPKO Health Inc.
F. Hoffmann-La Roche AG.
Market Segmentation (by Type)
Liquid Biopsy
Tissue Biopsy
Market Segmentation (by Application)
Hospitals/Clinics
Research Organization
Diagnostic Laboratories
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Lung Cancer Genomic Testing Market
- Overview of the regional outlook of the Lung Cancer Genomic Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Genomic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lung Cancer Genomic Testing
1.2 Key Market Segments
1.2.1 Lung Cancer Genomic Testing Segment by Type
1.2.2 Lung Cancer Genomic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER GENOMIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Genomic Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lung Cancer Genomic Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER GENOMIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Lung Cancer Genomic Testing Sales by Manufacturers (2019-2024)
3.2 Global Lung Cancer Genomic Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lung Cancer Genomic Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lung Cancer Genomic Testing Sales Sites, Area Served, Product Type
3.6 Lung Cancer Genomic Testing Market Competitive Situation and Trends
3.6.1 Lung Cancer Genomic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Genomic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER GENOMIC TESTING INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Genomic Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER GENOMIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LUNG CANCER GENOMIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Genomic Testing Sales Market Share by Type (2019-2024)
6.3 Global Lung Cancer Genomic Testing Market Size Market Share by Type (2019-2024)
6.4 Global Lung Cancer Genomic Testing Price by Type (2019-2024)
7 LUNG CANCER GENOMIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Genomic Testing Market Sales by Application (2019-2024)
7.3 Global Lung Cancer Genomic Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2019-2024)
8 LUNG CANCER GENOMIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Lung Cancer Genomic Testing Sales by Region
8.1.1 Global Lung Cancer Genomic Testing Sales by Region
8.1.2 Global Lung Cancer Genomic Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Genomic Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Genomic Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Genomic Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Genomic Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Genomic Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CD Genomics
9.1.1 CD Genomics Lung Cancer Genomic Testing Basic Information
9.1.2 CD Genomics Lung Cancer Genomic Testing Product Overview
9.1.3 CD Genomics Lung Cancer Genomic Testing Product Market Performance
9.1.4 CD Genomics Business Overview
9.1.5 CD Genomics Lung Cancer Genomic Testing SWOT Analysis
9.1.6 CD Genomics Recent Developments
9.2 Qiagen NV
9.2.1 Qiagen NV Lung Cancer Genomic Testing Basic Information
9.2.2 Qiagen NV Lung Cancer Genomic Testing Product Overview
9.2.3 Qiagen NV Lung Cancer Genomic Testing Product Market Performance
9.2.4 Qiagen NV Business Overview
9.2.5 Qiagen NV Lung Cancer Genomic Testing SWOT Analysis
9.2.6 Qiagen NV Recent Developments
9.3 Laboratory Corporation of America Holdings
9.3.1 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Basic Information
9.3.2 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Overview
9.3.3 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Market Performance
9.3.4 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing SWOT Analysis
9.3.5 Laboratory Corporation of America Holdings Business Overview
9.3.6 Laboratory Corporation of America Holdings Recent Developments
9.4 NeoGenomics Laboratories
9.4.1 NeoGenomics Laboratories Lung Cancer Genomic Testing Basic Information
9.4.2 NeoGenomics Laboratories Lung Cancer Genomic Testing Product Overview
9.4.3 NeoGenomics Laboratories Lung Cancer Genomic Testing Product Market Performance
9.4.4 NeoGenomics Laboratories Business Overview
9.4.5 NeoGenomics Laboratories Recent Developments
9.5 Agilent Technologies Inc.
9.5.1 Agilent Technologies Inc. Lung Cancer Genomic Testing Basic Information
9.5.2 Agilent Technologies Inc. Lung Cancer Genomic Testing Product Overview
9.5.3 Agilent Technologies Inc. Lung Cancer Genomic Testing Product Market Performance
9.5.4 Agilent Technologies Inc. Business Overview
9.5.5 Agilent Technologies Inc. Recent Developments
9.6 Illumina Inc.
9.6.1 Illumina Inc. Lung Cancer Genomic Testing Basic Information
9.6.2 Illumina Inc. Lung Cancer Genomic Testing Product Overview
9.6.3 Illumina Inc. Lung Cancer Genomic Testing Product Market Performance
9.6.4 Illumina Inc. Business Overview
9.6.5 Illumina Inc. Recent Developments
9.7 Thermo Fischer Scientific Inc.
9.7.1 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Basic Information
9.7.2 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Overview
9.7.3 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Market Performance
9.7.4 Thermo Fischer Scientific Inc. Business Overview
9.7.5 Thermo Fischer Scientific Inc. Recent Developments
9.8 Abbott Laboratories Inc.
9.8.1 Abbott Laboratories Inc. Lung Cancer Genomic Testing Basic Information
9.8.2 Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Overview
9.8.3 Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Market Performance
9.8.4 Abbott Laboratories Inc. Business Overview
9.8.5 Abbott Laboratories Inc. Recent Developments
9.9 Quest Diagnostics Inc.
9.9.1 Quest Diagnostics Inc. Lung Cancer Genomic Testing Basic Information
9.9.2 Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Overview
9.9.3 Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Market Performance
9.9.4 Quest Diagnostics Inc. Business Overview
9.9.5 Quest Diagnostics Inc. Recent Developments
9.10 OncoDNA
9.10.1 OncoDNA Lung Cancer Genomic Testing Basic Information
9.10.2 OncoDNA Lung Cancer Genomic Testing Product Overview
9.10.3 OncoDNA Lung Cancer Genomic Testing Product Market Performance
9.10.4 OncoDNA Business Overview
9.10.5 OncoDNA Recent Developments
9.11 Centogene N.V.
9.11.1 Centogene N.V. Lung Cancer Genomic Testing Basic Information
9.11.2 Centogene N.V. Lung Cancer Genomic Testing Product Overview
9.11.3 Centogene N.V. Lung Cancer Genomic Testing Product Market Performance
9.11.4 Centogene N.V. Business Overview
9.11.5 Centogene N.V. Recent Developments
9.12 Admera Health
9.12.1 Admera Health Lung Cancer Genomic Testing Basic Information
9.12.2 Admera Health Lung Cancer Genomic Testing Product Overview
9.12.3 Admera Health Lung Cancer Genomic Testing Product Market Performance
9.12.4 Admera Health Business Overview
9.12.5 Admera Health Recent Developments
9.13 CeGaT GmbH
9.13.1 CeGaT GmbH Lung Cancer Genomic Testing Basic Information
9.13.2 CeGaT GmbH Lung Cancer Genomic Testing Product Overview
9.13.3 CeGaT GmbH Lung Cancer Genomic Testing Product Market Performance
9.13.4 CeGaT GmbH Business Overview
9.13.5 CeGaT GmbH Recent Developments
9.14 OPKO Health Inc.
9.14.1 OPKO Health Inc. Lung Cancer Genomic Testing Basic Information
9.14.2 OPKO Health Inc. Lung Cancer Genomic Testing Product Overview
9.14.3 OPKO Health Inc. Lung Cancer Genomic Testing Product Market Performance
9.14.4 OPKO Health Inc. Business Overview
9.14.5 OPKO Health Inc. Recent Developments
9.15 F. Hoffmann-La Roche AG.
9.15.1 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Basic Information
9.15.2 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Overview
9.15.3 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Market Performance
9.15.4 F. Hoffmann-La Roche AG. Business Overview
9.15.5 F. Hoffmann-La Roche AG. Recent Developments
10 LUNG CANCER GENOMIC TESTING MARKET FORECAST BY REGION
10.1 Global Lung Cancer Genomic Testing Market Size Forecast
10.2 Global Lung Cancer Genomic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Genomic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Genomic Testing Market Size Forecast by Region
10.2.4 South America Lung Cancer Genomic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Genomic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Lung Cancer Genomic Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lung Cancer Genomic Testing by Type (2025-2030)
11.1.2 Global Lung Cancer Genomic Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lung Cancer Genomic Testing by Type (2025-2030)
11.2 Global Lung Cancer Genomic Testing Market Forecast by Application (2025-2030)
11.2.1 Global Lung Cancer Genomic Testing Sales (K Units) Forecast by Application
11.2.2 Global Lung Cancer Genomic Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lung Cancer Genomic Testing
1.2 Key Market Segments
1.2.1 Lung Cancer Genomic Testing Segment by Type
1.2.2 Lung Cancer Genomic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER GENOMIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Genomic Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lung Cancer Genomic Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER GENOMIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Lung Cancer Genomic Testing Sales by Manufacturers (2019-2024)
3.2 Global Lung Cancer Genomic Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lung Cancer Genomic Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lung Cancer Genomic Testing Sales Sites, Area Served, Product Type
3.6 Lung Cancer Genomic Testing Market Competitive Situation and Trends
3.6.1 Lung Cancer Genomic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Genomic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER GENOMIC TESTING INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Genomic Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER GENOMIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LUNG CANCER GENOMIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Genomic Testing Sales Market Share by Type (2019-2024)
6.3 Global Lung Cancer Genomic Testing Market Size Market Share by Type (2019-2024)
6.4 Global Lung Cancer Genomic Testing Price by Type (2019-2024)
7 LUNG CANCER GENOMIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Genomic Testing Market Sales by Application (2019-2024)
7.3 Global Lung Cancer Genomic Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2019-2024)
8 LUNG CANCER GENOMIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Lung Cancer Genomic Testing Sales by Region
8.1.1 Global Lung Cancer Genomic Testing Sales by Region
8.1.2 Global Lung Cancer Genomic Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Genomic Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Genomic Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Genomic Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Genomic Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Genomic Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CD Genomics
9.1.1 CD Genomics Lung Cancer Genomic Testing Basic Information
9.1.2 CD Genomics Lung Cancer Genomic Testing Product Overview
9.1.3 CD Genomics Lung Cancer Genomic Testing Product Market Performance
9.1.4 CD Genomics Business Overview
9.1.5 CD Genomics Lung Cancer Genomic Testing SWOT Analysis
9.1.6 CD Genomics Recent Developments
9.2 Qiagen NV
9.2.1 Qiagen NV Lung Cancer Genomic Testing Basic Information
9.2.2 Qiagen NV Lung Cancer Genomic Testing Product Overview
9.2.3 Qiagen NV Lung Cancer Genomic Testing Product Market Performance
9.2.4 Qiagen NV Business Overview
9.2.5 Qiagen NV Lung Cancer Genomic Testing SWOT Analysis
9.2.6 Qiagen NV Recent Developments
9.3 Laboratory Corporation of America Holdings
9.3.1 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Basic Information
9.3.2 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Overview
9.3.3 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Market Performance
9.3.4 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing SWOT Analysis
9.3.5 Laboratory Corporation of America Holdings Business Overview
9.3.6 Laboratory Corporation of America Holdings Recent Developments
9.4 NeoGenomics Laboratories
9.4.1 NeoGenomics Laboratories Lung Cancer Genomic Testing Basic Information
9.4.2 NeoGenomics Laboratories Lung Cancer Genomic Testing Product Overview
9.4.3 NeoGenomics Laboratories Lung Cancer Genomic Testing Product Market Performance
9.4.4 NeoGenomics Laboratories Business Overview
9.4.5 NeoGenomics Laboratories Recent Developments
9.5 Agilent Technologies Inc.
9.5.1 Agilent Technologies Inc. Lung Cancer Genomic Testing Basic Information
9.5.2 Agilent Technologies Inc. Lung Cancer Genomic Testing Product Overview
9.5.3 Agilent Technologies Inc. Lung Cancer Genomic Testing Product Market Performance
9.5.4 Agilent Technologies Inc. Business Overview
9.5.5 Agilent Technologies Inc. Recent Developments
9.6 Illumina Inc.
9.6.1 Illumina Inc. Lung Cancer Genomic Testing Basic Information
9.6.2 Illumina Inc. Lung Cancer Genomic Testing Product Overview
9.6.3 Illumina Inc. Lung Cancer Genomic Testing Product Market Performance
9.6.4 Illumina Inc. Business Overview
9.6.5 Illumina Inc. Recent Developments
9.7 Thermo Fischer Scientific Inc.
9.7.1 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Basic Information
9.7.2 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Overview
9.7.3 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Market Performance
9.7.4 Thermo Fischer Scientific Inc. Business Overview
9.7.5 Thermo Fischer Scientific Inc. Recent Developments
9.8 Abbott Laboratories Inc.
9.8.1 Abbott Laboratories Inc. Lung Cancer Genomic Testing Basic Information
9.8.2 Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Overview
9.8.3 Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Market Performance
9.8.4 Abbott Laboratories Inc. Business Overview
9.8.5 Abbott Laboratories Inc. Recent Developments
9.9 Quest Diagnostics Inc.
9.9.1 Quest Diagnostics Inc. Lung Cancer Genomic Testing Basic Information
9.9.2 Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Overview
9.9.3 Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Market Performance
9.9.4 Quest Diagnostics Inc. Business Overview
9.9.5 Quest Diagnostics Inc. Recent Developments
9.10 OncoDNA
9.10.1 OncoDNA Lung Cancer Genomic Testing Basic Information
9.10.2 OncoDNA Lung Cancer Genomic Testing Product Overview
9.10.3 OncoDNA Lung Cancer Genomic Testing Product Market Performance
9.10.4 OncoDNA Business Overview
9.10.5 OncoDNA Recent Developments
9.11 Centogene N.V.
9.11.1 Centogene N.V. Lung Cancer Genomic Testing Basic Information
9.11.2 Centogene N.V. Lung Cancer Genomic Testing Product Overview
9.11.3 Centogene N.V. Lung Cancer Genomic Testing Product Market Performance
9.11.4 Centogene N.V. Business Overview
9.11.5 Centogene N.V. Recent Developments
9.12 Admera Health
9.12.1 Admera Health Lung Cancer Genomic Testing Basic Information
9.12.2 Admera Health Lung Cancer Genomic Testing Product Overview
9.12.3 Admera Health Lung Cancer Genomic Testing Product Market Performance
9.12.4 Admera Health Business Overview
9.12.5 Admera Health Recent Developments
9.13 CeGaT GmbH
9.13.1 CeGaT GmbH Lung Cancer Genomic Testing Basic Information
9.13.2 CeGaT GmbH Lung Cancer Genomic Testing Product Overview
9.13.3 CeGaT GmbH Lung Cancer Genomic Testing Product Market Performance
9.13.4 CeGaT GmbH Business Overview
9.13.5 CeGaT GmbH Recent Developments
9.14 OPKO Health Inc.
9.14.1 OPKO Health Inc. Lung Cancer Genomic Testing Basic Information
9.14.2 OPKO Health Inc. Lung Cancer Genomic Testing Product Overview
9.14.3 OPKO Health Inc. Lung Cancer Genomic Testing Product Market Performance
9.14.4 OPKO Health Inc. Business Overview
9.14.5 OPKO Health Inc. Recent Developments
9.15 F. Hoffmann-La Roche AG.
9.15.1 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Basic Information
9.15.2 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Overview
9.15.3 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Market Performance
9.15.4 F. Hoffmann-La Roche AG. Business Overview
9.15.5 F. Hoffmann-La Roche AG. Recent Developments
10 LUNG CANCER GENOMIC TESTING MARKET FORECAST BY REGION
10.1 Global Lung Cancer Genomic Testing Market Size Forecast
10.2 Global Lung Cancer Genomic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Genomic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Genomic Testing Market Size Forecast by Region
10.2.4 South America Lung Cancer Genomic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Genomic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Lung Cancer Genomic Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lung Cancer Genomic Testing by Type (2025-2030)
11.1.2 Global Lung Cancer Genomic Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lung Cancer Genomic Testing by Type (2025-2030)
11.2 Global Lung Cancer Genomic Testing Market Forecast by Application (2025-2030)
11.2.1 Global Lung Cancer Genomic Testing Sales (K Units) Forecast by Application
11.2.2 Global Lung Cancer Genomic Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Genomic Testing Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Genomic Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Lung Cancer Genomic Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Lung Cancer Genomic Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Lung Cancer Genomic Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Genomic Testing as of 2022)
Table 10. Global Market Lung Cancer Genomic Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Lung Cancer Genomic Testing Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Genomic Testing Product Type
Table 13. Global Lung Cancer Genomic Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Lung Cancer Genomic Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lung Cancer Genomic Testing Market Challenges
Table 22. Global Lung Cancer Genomic Testing Sales by Type (K Units)
Table 23. Global Lung Cancer Genomic Testing Market Size by Type (M USD)
Table 24. Global Lung Cancer Genomic Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Lung Cancer Genomic Testing Sales Market Share by Type (2019-2024)
Table 26. Global Lung Cancer Genomic Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Lung Cancer Genomic Testing Market Size Share by Type (2019-2024)
Table 28. Global Lung Cancer Genomic Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Lung Cancer Genomic Testing Sales (K Units) by Application
Table 30. Global Lung Cancer Genomic Testing Market Size by Application
Table 31. Global Lung Cancer Genomic Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Lung Cancer Genomic Testing Sales Market Share by Application (2019-2024)
Table 33. Global Lung Cancer Genomic Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Lung Cancer Genomic Testing Market Share by Application (2019-2024)
Table 35. Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Lung Cancer Genomic Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Lung Cancer Genomic Testing Sales Market Share by Region (2019-2024)
Table 38. North America Lung Cancer Genomic Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Lung Cancer Genomic Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Lung Cancer Genomic Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Lung Cancer Genomic Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Lung Cancer Genomic Testing Sales by Region (2019-2024) & (K Units)
Table 43. CD Genomics Lung Cancer Genomic Testing Basic Information
Table 44. CD Genomics Lung Cancer Genomic Testing Product Overview
Table 45. CD Genomics Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. CD Genomics Business Overview
Table 47. CD Genomics Lung Cancer Genomic Testing SWOT Analysis
Table 48. CD Genomics Recent Developments
Table 49. Qiagen NV Lung Cancer Genomic Testing Basic Information
Table 50. Qiagen NV Lung Cancer Genomic Testing Product Overview
Table 51. Qiagen NV Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Qiagen NV Business Overview
Table 53. Qiagen NV Lung Cancer Genomic Testing SWOT Analysis
Table 54. Qiagen NV Recent Developments
Table 55. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Basic Information
Table 56. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Overview
Table 57. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing SWOT Analysis
Table 59. Laboratory Corporation of America Holdings Business Overview
Table 60. Laboratory Corporation of America Holdings Recent Developments
Table 61. NeoGenomics Laboratories Lung Cancer Genomic Testing Basic Information
Table 62. NeoGenomics Laboratories Lung Cancer Genomic Testing Product Overview
Table 63. NeoGenomics Laboratories Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. NeoGenomics Laboratories Business Overview
Table 65. NeoGenomics Laboratories Recent Developments
Table 66. Agilent Technologies Inc. Lung Cancer Genomic Testing Basic Information
Table 67. Agilent Technologies Inc. Lung Cancer Genomic Testing Product Overview
Table 68. Agilent Technologies Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Agilent Technologies Inc. Business Overview
Table 70. Agilent Technologies Inc. Recent Developments
Table 71. Illumina Inc. Lung Cancer Genomic Testing Basic Information
Table 72. Illumina Inc. Lung Cancer Genomic Testing Product Overview
Table 73. Illumina Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Illumina Inc. Business Overview
Table 75. Illumina Inc. Recent Developments
Table 76. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Basic Information
Table 77. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Overview
Table 78. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Thermo Fischer Scientific Inc. Business Overview
Table 80. Thermo Fischer Scientific Inc. Recent Developments
Table 81. Abbott Laboratories Inc. Lung Cancer Genomic Testing Basic Information
Table 82. Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Overview
Table 83. Abbott Laboratories Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Abbott Laboratories Inc. Business Overview
Table 85. Abbott Laboratories Inc. Recent Developments
Table 86. Quest Diagnostics Inc. Lung Cancer Genomic Testing Basic Information
Table 87. Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Overview
Table 88. Quest Diagnostics Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Quest Diagnostics Inc. Business Overview
Table 90. Quest Diagnostics Inc. Recent Developments
Table 91. OncoDNA Lung Cancer Genomic Testing Basic Information
Table 92. OncoDNA Lung Cancer Genomic Testing Product Overview
Table 93. OncoDNA Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. OncoDNA Business Overview
Table 95. OncoDNA Recent Developments
Table 96. Centogene N.V. Lung Cancer Genomic Testing Basic Information
Table 97. Centogene N.V. Lung Cancer Genomic Testing Product Overview
Table 98. Centogene N.V. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Centogene N.V. Business Overview
Table 100. Centogene N.V. Recent Developments
Table 101. Admera Health Lung Cancer Genomic Testing Basic Information
Table 102. Admera Health Lung Cancer Genomic Testing Product Overview
Table 103. Admera Health Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Admera Health Business Overview
Table 105. Admera Health Recent Developments
Table 106. CeGaT GmbH Lung Cancer Genomic Testing Basic Information
Table 107. CeGaT GmbH Lung Cancer Genomic Testing Product Overview
Table 108. CeGaT GmbH Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. CeGaT GmbH Business Overview
Table 110. CeGaT GmbH Recent Developments
Table 111. OPKO Health Inc. Lung Cancer Genomic Testing Basic Information
Table 112. OPKO Health Inc. Lung Cancer Genomic Testing Product Overview
Table 113. OPKO Health Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. OPKO Health Inc. Business Overview
Table 115. OPKO Health Inc. Recent Developments
Table 116. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Basic Information
Table 117. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Overview
Table 118. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. F. Hoffmann-La Roche AG. Business Overview
Table 120. F. Hoffmann-La Roche AG. Recent Developments
Table 121. Global Lung Cancer Genomic Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Lung Cancer Genomic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Lung Cancer Genomic Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Lung Cancer Genomic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Lung Cancer Genomic Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Lung Cancer Genomic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Lung Cancer Genomic Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Lung Cancer Genomic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Lung Cancer Genomic Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Lung Cancer Genomic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Lung Cancer Genomic Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Lung Cancer Genomic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Lung Cancer Genomic Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Lung Cancer Genomic Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Lung Cancer Genomic Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Lung Cancer Genomic Testing Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Lung Cancer Genomic Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Genomic Testing Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Genomic Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Lung Cancer Genomic Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Lung Cancer Genomic Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Lung Cancer Genomic Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Genomic Testing as of 2022)
Table 10. Global Market Lung Cancer Genomic Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Lung Cancer Genomic Testing Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Genomic Testing Product Type
Table 13. Global Lung Cancer Genomic Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Lung Cancer Genomic Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lung Cancer Genomic Testing Market Challenges
Table 22. Global Lung Cancer Genomic Testing Sales by Type (K Units)
Table 23. Global Lung Cancer Genomic Testing Market Size by Type (M USD)
Table 24. Global Lung Cancer Genomic Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Lung Cancer Genomic Testing Sales Market Share by Type (2019-2024)
Table 26. Global Lung Cancer Genomic Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Lung Cancer Genomic Testing Market Size Share by Type (2019-2024)
Table 28. Global Lung Cancer Genomic Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Lung Cancer Genomic Testing Sales (K Units) by Application
Table 30. Global Lung Cancer Genomic Testing Market Size by Application
Table 31. Global Lung Cancer Genomic Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Lung Cancer Genomic Testing Sales Market Share by Application (2019-2024)
Table 33. Global Lung Cancer Genomic Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Lung Cancer Genomic Testing Market Share by Application (2019-2024)
Table 35. Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Lung Cancer Genomic Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Lung Cancer Genomic Testing Sales Market Share by Region (2019-2024)
Table 38. North America Lung Cancer Genomic Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Lung Cancer Genomic Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Lung Cancer Genomic Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Lung Cancer Genomic Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Lung Cancer Genomic Testing Sales by Region (2019-2024) & (K Units)
Table 43. CD Genomics Lung Cancer Genomic Testing Basic Information
Table 44. CD Genomics Lung Cancer Genomic Testing Product Overview
Table 45. CD Genomics Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. CD Genomics Business Overview
Table 47. CD Genomics Lung Cancer Genomic Testing SWOT Analysis
Table 48. CD Genomics Recent Developments
Table 49. Qiagen NV Lung Cancer Genomic Testing Basic Information
Table 50. Qiagen NV Lung Cancer Genomic Testing Product Overview
Table 51. Qiagen NV Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Qiagen NV Business Overview
Table 53. Qiagen NV Lung Cancer Genomic Testing SWOT Analysis
Table 54. Qiagen NV Recent Developments
Table 55. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Basic Information
Table 56. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product Overview
Table 57. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing SWOT Analysis
Table 59. Laboratory Corporation of America Holdings Business Overview
Table 60. Laboratory Corporation of America Holdings Recent Developments
Table 61. NeoGenomics Laboratories Lung Cancer Genomic Testing Basic Information
Table 62. NeoGenomics Laboratories Lung Cancer Genomic Testing Product Overview
Table 63. NeoGenomics Laboratories Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. NeoGenomics Laboratories Business Overview
Table 65. NeoGenomics Laboratories Recent Developments
Table 66. Agilent Technologies Inc. Lung Cancer Genomic Testing Basic Information
Table 67. Agilent Technologies Inc. Lung Cancer Genomic Testing Product Overview
Table 68. Agilent Technologies Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Agilent Technologies Inc. Business Overview
Table 70. Agilent Technologies Inc. Recent Developments
Table 71. Illumina Inc. Lung Cancer Genomic Testing Basic Information
Table 72. Illumina Inc. Lung Cancer Genomic Testing Product Overview
Table 73. Illumina Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Illumina Inc. Business Overview
Table 75. Illumina Inc. Recent Developments
Table 76. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Basic Information
Table 77. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product Overview
Table 78. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Thermo Fischer Scientific Inc. Business Overview
Table 80. Thermo Fischer Scientific Inc. Recent Developments
Table 81. Abbott Laboratories Inc. Lung Cancer Genomic Testing Basic Information
Table 82. Abbott Laboratories Inc. Lung Cancer Genomic Testing Product Overview
Table 83. Abbott Laboratories Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Abbott Laboratories Inc. Business Overview
Table 85. Abbott Laboratories Inc. Recent Developments
Table 86. Quest Diagnostics Inc. Lung Cancer Genomic Testing Basic Information
Table 87. Quest Diagnostics Inc. Lung Cancer Genomic Testing Product Overview
Table 88. Quest Diagnostics Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Quest Diagnostics Inc. Business Overview
Table 90. Quest Diagnostics Inc. Recent Developments
Table 91. OncoDNA Lung Cancer Genomic Testing Basic Information
Table 92. OncoDNA Lung Cancer Genomic Testing Product Overview
Table 93. OncoDNA Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. OncoDNA Business Overview
Table 95. OncoDNA Recent Developments
Table 96. Centogene N.V. Lung Cancer Genomic Testing Basic Information
Table 97. Centogene N.V. Lung Cancer Genomic Testing Product Overview
Table 98. Centogene N.V. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Centogene N.V. Business Overview
Table 100. Centogene N.V. Recent Developments
Table 101. Admera Health Lung Cancer Genomic Testing Basic Information
Table 102. Admera Health Lung Cancer Genomic Testing Product Overview
Table 103. Admera Health Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Admera Health Business Overview
Table 105. Admera Health Recent Developments
Table 106. CeGaT GmbH Lung Cancer Genomic Testing Basic Information
Table 107. CeGaT GmbH Lung Cancer Genomic Testing Product Overview
Table 108. CeGaT GmbH Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. CeGaT GmbH Business Overview
Table 110. CeGaT GmbH Recent Developments
Table 111. OPKO Health Inc. Lung Cancer Genomic Testing Basic Information
Table 112. OPKO Health Inc. Lung Cancer Genomic Testing Product Overview
Table 113. OPKO Health Inc. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. OPKO Health Inc. Business Overview
Table 115. OPKO Health Inc. Recent Developments
Table 116. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Basic Information
Table 117. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product Overview
Table 118. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. F. Hoffmann-La Roche AG. Business Overview
Table 120. F. Hoffmann-La Roche AG. Recent Developments
Table 121. Global Lung Cancer Genomic Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Lung Cancer Genomic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Lung Cancer Genomic Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Lung Cancer Genomic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Lung Cancer Genomic Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Lung Cancer Genomic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Lung Cancer Genomic Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Lung Cancer Genomic Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Lung Cancer Genomic Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Lung Cancer Genomic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Lung Cancer Genomic Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Lung Cancer Genomic Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Lung Cancer Genomic Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Lung Cancer Genomic Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Lung Cancer Genomic Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Lung Cancer Genomic Testing Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Lung Cancer Genomic Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Lung Cancer Genomic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Genomic Testing Market Size (M USD), 2019-2030
Figure 5. Global Lung Cancer Genomic Testing Market Size (M USD) (2019-2030)
Figure 6. Global Lung Cancer Genomic Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Genomic Testing Market Size by Country (M USD)
Figure 11. Lung Cancer Genomic Testing Sales Share by Manufacturers in 2023
Figure 12. Global Lung Cancer Genomic Testing Revenue Share by Manufacturers in 2023
Figure 13. Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Lung Cancer Genomic Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Genomic Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Lung Cancer Genomic Testing Market Share by Type
Figure 18. Sales Market Share of Lung Cancer Genomic Testing by Type (2019-2024)
Figure 19. Sales Market Share of Lung Cancer Genomic Testing by Type in 2023
Figure 20. Market Size Share of Lung Cancer Genomic Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Lung Cancer Genomic Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lung Cancer Genomic Testing Market Share by Application
Figure 24. Global Lung Cancer Genomic Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Lung Cancer Genomic Testing Sales Market Share by Application in 2023
Figure 26. Global Lung Cancer Genomic Testing Market Share by Application (2019-2024)
Figure 27. Global Lung Cancer Genomic Testing Market Share by Application in 2023
Figure 28. Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Lung Cancer Genomic Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Lung Cancer Genomic Testing Sales Market Share by Country in 2023
Figure 32. U.S. Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Lung Cancer Genomic Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Lung Cancer Genomic Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Lung Cancer Genomic Testing Sales Market Share by Country in 2023
Figure 37. Germany Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Lung Cancer Genomic Testing Sales Market Share by Region in 2023
Figure 44. China Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 50. South America Lung Cancer Genomic Testing Sales Market Share by Country in 2023
Figure 51. Brazil Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Lung Cancer Genomic Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Lung Cancer Genomic Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Lung Cancer Genomic Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Lung Cancer Genomic Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Lung Cancer Genomic Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Lung Cancer Genomic Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Lung Cancer Genomic Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Lung Cancer Genomic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Genomic Testing Market Size (M USD), 2019-2030
Figure 5. Global Lung Cancer Genomic Testing Market Size (M USD) (2019-2030)
Figure 6. Global Lung Cancer Genomic Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Genomic Testing Market Size by Country (M USD)
Figure 11. Lung Cancer Genomic Testing Sales Share by Manufacturers in 2023
Figure 12. Global Lung Cancer Genomic Testing Revenue Share by Manufacturers in 2023
Figure 13. Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Lung Cancer Genomic Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Genomic Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Lung Cancer Genomic Testing Market Share by Type
Figure 18. Sales Market Share of Lung Cancer Genomic Testing by Type (2019-2024)
Figure 19. Sales Market Share of Lung Cancer Genomic Testing by Type in 2023
Figure 20. Market Size Share of Lung Cancer Genomic Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Lung Cancer Genomic Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lung Cancer Genomic Testing Market Share by Application
Figure 24. Global Lung Cancer Genomic Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Lung Cancer Genomic Testing Sales Market Share by Application in 2023
Figure 26. Global Lung Cancer Genomic Testing Market Share by Application (2019-2024)
Figure 27. Global Lung Cancer Genomic Testing Market Share by Application in 2023
Figure 28. Global Lung Cancer Genomic Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Lung Cancer Genomic Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Lung Cancer Genomic Testing Sales Market Share by Country in 2023
Figure 32. U.S. Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Lung Cancer Genomic Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Lung Cancer Genomic Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Lung Cancer Genomic Testing Sales Market Share by Country in 2023
Figure 37. Germany Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Lung Cancer Genomic Testing Sales Market Share by Region in 2023
Figure 44. China Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 50. South America Lung Cancer Genomic Testing Sales Market Share by Country in 2023
Figure 51. Brazil Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Lung Cancer Genomic Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Lung Cancer Genomic Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Lung Cancer Genomic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Lung Cancer Genomic Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Lung Cancer Genomic Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Lung Cancer Genomic Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Lung Cancer Genomic Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Lung Cancer Genomic Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Lung Cancer Genomic Testing Market Share Forecast by Application (2025-2030)
